# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-26-034938
Filing Date
2026-07-28
Accepted
2026-07-28 08:34:27
Documents
47
Period of Report
2026-07-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | form6-k.htm | 6-K | 24628
2 | EX-99.1 | ex99-1.htm | EX-99.1 | 15858
3 | EX-99.2 | ex99-2.htm | EX-99.2 | 30570
4 | GRAPHIC | ex99-2_001.jpg | GRAPHIC | 765246
5 | GRAPHIC | ex99-2_002.jpg | GRAPHIC | 903718
6 | GRAPHIC | ex99-2_003.jpg | GRAPHIC | 438530
7 | GRAPHIC | ex99-2_004.jpg | GRAPHIC | 373801
8 | GRAPHIC | ex99-2_005.jpg | GRAPHIC | 899305
9 | GRAPHIC | ex99-2_006.jpg | GRAPHIC | 656328
10 | GRAPHIC | ex99-2_007.jpg | GRAPHIC | 669904
11 | GRAPHIC | ex99-2_008.jpg | GRAPHIC | 404814
12 | GRAPHIC | ex99-2_009.jpg | GRAPHIC | 493491
13 | GRAPHIC | ex99-2_010.jpg | GRAPHIC | 325471
14 | GRAPHIC | ex99-2_011.jpg | GRAPHIC | 465466
15 | GRAPHIC | ex99-2_012.jpg | GRAPHIC | 486893
16 | GRAPHIC | ex99-2_013.jpg | GRAPHIC | 1028297
17 | GRAPHIC | ex99-2_014.jpg | GRAPHIC | 455417
18 | GRAPHIC | ex99-2_015.jpg | GRAPHIC | 391325
19 | GRAPHIC | ex99-2_016.jpg | GRAPHIC | 288621
20 | GRAPHIC | ex99-2_017.jpg | GRAPHIC | 277395
21 | GRAPHIC | ex99-2_018.jpg | GRAPHIC | 277446
22 | GRAPHIC | ex99-2_019.jpg | GRAPHIC | 344186
23 | GRAPHIC | ex99-2_020.jpg | GRAPHIC | 221424
24 | GRAPHIC | ex99-2_021.jpg | GRAPHIC | 393701
25 | GRAPHIC | ex99-2_022.jpg | GRAPHIC | 359351
26 | GRAPHIC | ex99-2_023.jpg | GRAPHIC | 414029
27 | GRAPHIC | ex99-2_024.jpg | GRAPHIC | 424161
28 | GRAPHIC | ex99-2_025.jpg | GRAPHIC | 447520
29 | GRAPHIC | ex99-2_026.jpg | GRAPHIC | 514351
30 | GRAPHIC | ex99-2_027.jpg | GRAPHIC | 624577
31 | GRAPHIC | ex99-2_028.jpg | GRAPHIC | 956894
32 | GRAPHIC | ex99-2_029.jpg | GRAPHIC | 768211
33 | GRAPHIC | ex99-2_030.jpg | GRAPHIC | 622844
34 | GRAPHIC | ex99-2_031.jpg | GRAPHIC | 253053
35 | GRAPHIC | ex99-2_032.jpg | GRAPHIC | 362240
36 | GRAPHIC | ex99-2_033.jpg | GRAPHIC | 248608
37 | GRAPHIC | ex99-2_034.jpg | GRAPHIC | 358562
38 | GRAPHIC | ex99-2_035.jpg | GRAPHIC | 425313
39 | GRAPHIC | ex99-2_036.jpg | GRAPHIC | 1008192
40 | GRAPHIC | ex99-2_037.jpg | GRAPHIC | 304510
41 | GRAPHIC | ex99-2_038.jpg | GRAPHIC | 315977
42 | GRAPHIC | ex99-2_039.jpg | GRAPHIC | 267070
43 | GRAPHIC | ex99-2_040.jpg | GRAPHIC | 288885
44 | GRAPHIC | ex99-2_041.jpg | GRAPHIC | 399283
45 | GRAPHIC | ex99-2_042.jpg | GRAPHIC | 416381
46 | GRAPHIC | ex99-2_043.jpg | GRAPHIC | 579402
47 | GRAPHIC | ex99-2_044.jpg | GRAPHIC | 374986
| Complete submission text file | 0001493152-26-034938.txt |  | 29406088

Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42796 | Film No.: 261207622
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)